Enamine Ltd. established in Kiev in 1991, has signed a collaboration agreement to provide the European Molecular Biology Laboratory (EMBL) with library synthesis, medicinal chemistry and biological services for the discovery and development of novel small molecules against EMBL’s proprietary anti-cancer targets. The Enamine’s dedicated team will focus on the project’s multiple objectives towards creating new cancer therapeutics with novel modes of action.